292 related articles for article (PubMed ID: 18844453)
1. Quantitative expression analysis and prognostic significance of the novel apoptosis-related gene BCL2L12 in colon cancer.
Kontos CK; Papadopoulos IN; Scorilas A
Biol Chem; 2008 Dec; 389(12):1467-75. PubMed ID: 18844453
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer.
Thomadaki H; Talieri M; Scorilas A
Cancer Lett; 2007 Mar; 247(1):48-55. PubMed ID: 16647810
[TBL] [Abstract][Full Text] [Related]
3. Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer.
Mathioudaki K; Scorilas A; Papadokostopoulou A; Xynopoulos D; Arnogianaki N; Agnanti N; Talieri M
Biol Chem; 2004 Sep; 385(9):779-83. PubMed ID: 15493871
[TBL] [Abstract][Full Text] [Related]
4. Molecular analysis and prognostic impact of the novel apoptotic gene BCL2L12 in gastric cancer.
Florou D; Papadopoulos IN; Scorilas A
Biochem Biophys Res Commun; 2010 Jan; 391(1):214-8. PubMed ID: 19903463
[TBL] [Abstract][Full Text] [Related]
5. Quantitative expression analysis of the apoptosis-related gene, BCL2L12, in head and neck squamous cell carcinoma.
Geomela PA; Kontos CK; Yiotakis I; Scorilas A
J Oral Pathol Med; 2013 Feb; 42(2):154-61. PubMed ID: 22747515
[TBL] [Abstract][Full Text] [Related]
6. Expression analysis and study of KLK4 in benign and malignant breast tumours.
Papachristopoulou G; Avgeris M; Scorilas A
Thromb Haemost; 2009 Feb; 101(2):381-7. PubMed ID: 19190825
[TBL] [Abstract][Full Text] [Related]
7. Topotecan and methotrexate alter expression of the apoptosis-related genes BCL2, FAS and BCL2L12 in leukemic HL-60 cells.
Floros KV; Talieri M; Scorilas A
Biol Chem; 2006 Dec; 387(12):1629-33. PubMed ID: 17132110
[TBL] [Abstract][Full Text] [Related]
8. BCL2L12: a promising molecular prognostic biomarker in breast cancer.
Tzovaras A; Kladi-Skandali A; Michaelidou K; Zografos GC; Missitzis I; Ardavanis A; Scorilas A
Clin Biochem; 2014 Dec; 47(18):257-62. PubMed ID: 25230343
[TBL] [Abstract][Full Text] [Related]
9. Expression of transferrin receptor and ferritin H-chain mRNA are associated with clinical and histopathological prognostic indicators in breast cancer.
Yang DC; Wang F; Elliott RL; Head JF
Anticancer Res; 2001; 21(1B):541-9. PubMed ID: 11299801
[TBL] [Abstract][Full Text] [Related]
10. Alterations in mRNA expression of apoptosis-related genes BCL2, BAX, FAS, caspase-3, and the novel member BCL2L12 after treatment of human leukemic cell line HL60 with the antineoplastic agent etoposide.
Floros KV; Thomadaki H; Florou D; Talieri M; Scorilas A
Ann N Y Acad Sci; 2006 Dec; 1090():89-97. PubMed ID: 17384250
[TBL] [Abstract][Full Text] [Related]
11. Molecular response of HL-60 cells to mitotic inhibitors vincristine and taxol visualized with apoptosis-related gene expressions, including the new member BCL2L12.
Thomadaki H; Floros KV; Scorilas A
Ann N Y Acad Sci; 2009 Aug; 1171():276-83. PubMed ID: 19723066
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12.
Thomadaki H; Scorilas A
Ann N Y Acad Sci; 2007 Jan; 1095():35-44. PubMed ID: 17404015
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the novel member of the BCL2 gene family, BCL2L12, is associated with the disease outcome in patients with acute myeloid leukemia.
Thomadaki H; Floros KV; Pavlovic S; Tosic N; Gourgiotis D; Colovic M; Scorilas A
Clin Biochem; 2012 Nov; 45(16-17):1362-7. PubMed ID: 22728012
[TBL] [Abstract][Full Text] [Related]
14. Expression of BCL2L12, a new member of apoptosis-related genes, in breast tumors.
Talieri M; Diamandis EP; Katsaros N; Gourgiotis D; Scorilas A
Thromb Haemost; 2003 Jun; 89(6):1081-8. PubMed ID: 12783122
[TBL] [Abstract][Full Text] [Related]
15. BCL2L12 is a novel biomarker for the prediction of short-term relapse in nasopharyngeal carcinoma.
Fendri A; Kontos CK; Khabir A; Mokdad-Gargouri R; Scorilas A
Mol Med; 2011; 17(3-4):163-71. PubMed ID: 21152697
[TBL] [Abstract][Full Text] [Related]
16. Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS.
Thomadaki H; Talieri M; Scorilas A
Biol Chem; 2006 Aug; 387(8):1081-6. PubMed ID: 16895478
[TBL] [Abstract][Full Text] [Related]
17. Thymidylate synthase expression correlates closely with E2F1 expression in colon cancer.
Kasahara M; Takahashi Y; Nagata T; Asai S; Eguchi T; Ishii Y; Fujii M; Ishikawa K
Clin Cancer Res; 2000 Jul; 6(7):2707-11. PubMed ID: 10914714
[TBL] [Abstract][Full Text] [Related]
18. Increased BCL2L12 expression predicts the short-term relapse of patients with TaT1 bladder cancer following transurethral resection of bladder tumors.
Foutadakis S; Avgeris M; Tokas T; Stravodimos K; Scorilas A
Urol Oncol; 2014 Jan; 32(1):39.e29-36. PubMed ID: 23790536
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of humbug gene overexpression in stage II colon cancer.
Wang J; de la Monte SM; Sabo E; Kethu S; Tavares R; Branda M; Simao L; Wands JR; Resnick MB
Hum Pathol; 2007 Jan; 38(1):17-25. PubMed ID: 17020779
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis regulating genes, bcl-2 and bax, and human telomerase reverse transcriptase messenger RNA expression in adrenal tumors: possible diagnostic and prognostic importance.
Kanauchi H; Wada N; Clark OH; Duh QY
Surgery; 2002 Dec; 132(6):1021-6; discussion 1026-7. PubMed ID: 12490850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
